Last reviewed · How we verify

NCT04165876

HD-tDCS: Effects on the Somatosensory System

Completed NA Last updated 11 June 2020
What this trial tests

NA trial testing Primary Motor Cortex Stimulation in Acute Pain in 81 participants. Completed in 18 March 2020.

Timeline
18 December 2018
Primary endpoint
18 February 2020
18 March 2020

Quick facts

Lead sponsorAalborg University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposebasic science
Enrollment81
Start date18 December 2018
Primary completion18 February 2020
Estimated completion18 March 2020
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aalborg University

Who can join

Adults 18 to 60, any sex, with Acute Pain or Neuroplasticity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the efficacy of high definition tDCS on different cortical targets in modulating the nociceptive system in the healthy subjects.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Modulation of central pain mechanisms using high-definition transcranial direct current stimulation: A double-blind, sham-controlled study.
    Kold S, Graven-Nielsen T. · · 2023 · cited 6× · PMID 36451616 · DOI 10.1002/ejp.2060

Verify or expand the search:

Other recruiting trials for Acute Pain

Currently open trials in the same condition.

Other Aalborg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04165876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing